SG Americas Securities’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-59,342
| Closed | -$2.28M | – | 3322 |
|
|
2023
Q2 | $2.28M | Sell |
59,342
-94,540
| -61% | -$2.43M | 0.02% | 677 |
|
|
2023
Q1 | $3.56M | Buy |
153,882
+145,861
| +1,818% | +$3.48M | 0.04% | 393 |
|
|
2022
Q4 | $210K | Sell |
8,021
-20,020
| -71% | -$444K | ﹤0.01% | 2158 |
|
|
2022
Q3 | $551K | Buy |
28,041
+3,775
| +16% | +$75.7K | 0.01% | 1468 |
|
|
2022
Q2 | $424K | Buy |
+24,266
| New | +$381K | ﹤0.01% | 2110 |
|
|
2022
Q1 | – | Sell |
-10,978
| Closed | -$179K | – | 3592 |
|
|
2021
Q4 | $179K | Sell |
10,978
-11,666
| -52% | -$166K | ﹤0.01% | 2732 |
|
|
2021
Q3 | $289K | Buy |
+22,644
| New | +$298K | ﹤0.01% | 2976 |
|
|
2020
Q3 | – | Sell |
-7,233
| Closed | -$84K | – | 3654 |
|
|
2020
Q2 | $84K | Buy |
7,233
+2,540
| +54% | +$35K | ﹤0.01% | 3434 |
|
|
2020
Q1 | $64K | Buy |
4,693
+1,653
| +54% | +$19.5K | ﹤0.01% | 3134 |
|
|
2019
Q4 | $18K | Buy |
+3,040
| New | +$16.5K | ﹤0.01% | 3154 |
|
|
2019
Q3 | – | Sell |
-4,935
| Closed | -$38K | – | 3294 |
|
|
2019
Q2 | $38K | Buy |
4,935
+295
| +6% | +$4.49K | ﹤0.01% | 2951 |
|
|
2019
Q1 | $92K | Buy |
4,640
+1,457
| +46% | +$25.4K | ﹤0.01% | 3086 |
|
|
2018
Q4 | $42K | Buy |
+3,183
| New | +$63.6K | ﹤0.01% | 2843 |
|
|
2017
Q4 | – | Sell |
-3,141
| Closed | -$167K | – | 3750 |
|
|
2017
Q3 | $167K | Buy |
+3,141
| New | +$187K | ﹤0.01% | 2744 |
|
|
2017
Q2 | – | Sell |
-3,771
| Closed | -$203K | – | 3614 |
|
|
2017
Q1 | $203K | Sell |
3,771
-1,082
| -22% | -$61.1K | ﹤0.01% | 2427 |
|
|
2016
Q4 | $277K | Buy |
+4,853
| New | +$294K | ﹤0.01% | 2098 |
|
SG Americas Securities's KDNY Position: Q3 2023 in Review
SG Americas Securities sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q3 2023, closing a stake of 59,342 shares — an estimated $2.28M sold.
SG Americas Securities first reported a position in KDNY in Q4 2016 and held it in 16 quarters. The position peaked at $3.56M in Q1 2023. 2 funds tracked by Wall St. Rank hold KDNY as of Q3 2023.
- SG Americas Securities reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
- SG Americas Securities sold 59,342 Chinook Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $2.28M.
- SG Americas Securities first reported a position in Chinook Therapeutics, Inc. Common Stock in Q4 2016 and held it in 16 quarters.
- SG Americas Securities's Chinook Therapeutics, Inc. Common Stock position peaked at $3.56M in Q1 2023.
- 2 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q3 2023.
Based on SG Americas Securities's 13F filing for Q3 2023, filed 13 Oct 2023.